Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study - Summary - MDSpire

Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study

  • By

  • Anna Palmisano

  • Chiara Gnasso

  • Alberto Cereda

  • Davide Vignale

  • Riccardo Leone

  • Valeria Nicoletti

  • Simone Barbieri

  • Marco Toselli

  • Francesco Giannini

  • Marco Loffi

  • Gianluigi Patelli

  • Alberto Monello

  • Gianmarco Iannopollo

  • Davide Ippolito

  • Elisabetta Maria Mancini

  • Gianluca Pontone

  • Luigi Vignali

  • Elisa Scarnecchia

  • Mario Iannaccone

  • Lucio Baffoni

  • Massimiliano Spernadio

  • Caterina Chiara de Carlini

  • Sandro Sironi

  • Claudio Rapezzi

  • Antonio Esposito

  • May 11, 2023

  • 0 min

Share

Objective:

To investigate the incremental value of multiparametric CT analysis over clinical data for phenotyping high-risk COVID-19 patients, thereby enhancing conventional risk stratification.

Key Findings:
  • Chest CT provides valuable prognostic information regarding pneumonia severity and cardiovascular risk, which can inform treatment decisions.
  • CT analysis can identify comorbidities and patient fragility through objective assessment of organ attenuation, aiding in personalized care.
  • Pneumonia extension and coronary artery calcium scores correlate with disease severity and patient outcomes, highlighting the need for integrated assessment.
Interpretation:

The study suggests that chest CT can enhance risk stratification in COVID-19 patients by providing additional biomarkers related to comorbidities and disease severity, potentially improving patient management.

Limitations:
  • Retrospective design may introduce bias; future studies should consider prospective designs.
  • Exclusion of patients with contrast-enhanced CT scans may limit generalizability; future research should include diverse imaging techniques.
  • Potential missing data due to overwhelmed emergency departments; strategies to improve data collection should be explored.
Conclusion:

Chest CT can serve as a valuable tool for improving the risk stratification of high-risk COVID-19 patients by providing comprehensive insights into their clinical status and comorbidities, which is crucial in the ongoing management of the pandemic.

Original Source(s)

Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study

  • by Anna Palmisano, Chiara Gnasso, Alberto Cereda, Davide Vignale, Riccardo Leone, Valeria Nicoletti, Simone Barbieri, Marco Toselli, Francesco Giannini, Marco Loffi, Gianluigi Patelli, Alberto Monello, Gianmarco Iannopollo, Davide Ippolito, Elisabetta Maria Mancini, Gianluca Pontone, Luigi Vignali, Elisa Scarnecchia, Mario Iannaccone, Lucio Baffoni, Massimiliano Spernadio, Caterina Chiara de Carlini, Sandro Sironi, Claudio Rapezzi, Antonio Esposito

  • May 11, 2023

Related Content

Respiratory viral infections today, heart failure tomorrow: implications for prevention

Leukemia Case Prompts Broader Review

Researchers assess hematologic malignancies temporally associated with mRNA COVID-19 vaccination.

Early Enteral Feeding Tied to Fewer Complications

Benefit driven by fewer infections and pulmonary events, though overall complication rates were similar